<?xml version="1.0" encoding="UTF-8"?>
<p>4-(4-(1-(3-Bromo-benzyl)-1H-indol-3-yl)butanamido)-N-hydroxybenzamide (
 <bold>I8</bold>). HRMS (AP-ESI) 
 <italic>m/z</italic> calcd for C
 <sub>26</sub>H
 <sub>24</sub>BrN
 <sub>3</sub>O
 <sub>3</sub> [M + H]
 <sup>+</sup> 506.39106, found 506.10611. 
 <sup>1</sup>H NMR (400 MHz, DMSO) 
 <italic>δ</italic> 11.09 (s, 1H), 10.11 (s, 1H), 8.93 (s, 1H), 7.67 (dd, 
 <italic>J</italic> = 18.4, 8.8 Hz, 4H), 7.56 (d, 
 <italic>J</italic> = 7.8 Hz, 1H), 7.44–7.41 (m, 3H), 7.33 (s, 1H), 7.28–7.24 (m, 1H), 7.16 (d, 
 <italic>J</italic> = 7.6 Hz, 1H), 7.12–7.08 (m, 1H), 7.03–6.99 (m, 1H), 5.37 (s, 2H), 2.75 (t, 
 <italic>J</italic> = 7.5 Hz, 2H), 2.42 (t, 
 <italic>J</italic> = 7.2 Hz, 2H), 2.02–1.95 (m, 2H); 
 <sup>13</sup>C NMR (400 MHz, DMSO): 
 <italic>δ</italic> = 172.04, 164.44, 142.35, 141.78, 136.52, 131.20, 130.61, 130.15, 128.28, 128.13, 127.41, 126.68, 126.50, 122.24, 121.83, 119.28, 119.13, 118.76, 114.83, 110.43, 48.62, 36.68, 26.21, 24.63 ppm.
</p>
